Using Functional Proprioceptive Stimulation to aid recovery after stroke
Early Functional Proprioceptive Stimulation Post-stroke
NA · Centre Hospitalier Universitaire de Nice · NCT06192953
This study is testing if a new type of stimulation can help people recovering from a stroke improve their movement and balance faster.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 32 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice (other) |
| Locations | 1 site (Nice) |
| Trial ID | NCT06192953 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of Functional Proprioceptive Stimulation (FPS) on the recovery of postural and motor functions in patients during the subacute phase following a stroke. Participants will be randomly assigned to either an active FPS group or a control group receiving non-activated stimulation. The study aims to determine if FPS can enhance functional abilities and reduce the time needed for sit-to-stand transfers. The intervention consists of five sessions per week over a maximum of six weeks.
Who should consider this trial
Good fit: Ideal candidates include adults hospitalized with a recent ischemic or hemorrhagic stroke and experiencing hemiparesis.
Not a fit: Patients with severe neurological impairment (NIHSS > 20) or significant muscle spasticity may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes for stroke patients.
How similar studies have performed: While the specific use of FPS is novel, similar rehabilitation approaches have shown promise in enhancing recovery post-stroke.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient hospitalized at Cimiez University Hospital; * Ischemic or hemorrhagic cerebrovascular accident (CVA) of less than two weeks; * Hemiparesis requiring rehabilitation treatment; * Patient with a SFPASS score ≤ 6; * Patient affiliated to or beneficiary of a social security scheme; * Signature of informed consent Exclusion criteria : * NIHSS \> 20; * Muscle spasticity of the lower limbs requiring botulinum toxin injection * Inability to understand rehabilitation instructions; * Vulnerable people * Pregnant women, parturients and breastfeeding mothers, persons deprived of their liberty by a judicial or administrative decision, persons hospitalized without consent and persons admitted to a health or social establishment for purposes other than research, * Adults who are subject to a legal protection measure or who are unable to express their consent.
Where this trial is running
Nice
- CHU de Nice — Nice, France (RECRUITING)
Study contacts
- Study coordinator: Guillaume SACCO, MD
- Email: sacco.g@chu-nice.fr
- Phone: 04 92 03 47 51
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke or TIA